Offit Capital Advisors LLC cut its stake in shares of Kimberly-Clark Co. (NYSE:KMB – Get Rating) by 6.2% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,083 shares of the company’s stock after selling 137 shares during the quarter. Offit Capital Advisors LLC’s holdings in Kimberly-Clark were worth $257,000 as of its most recent SEC filing.
Several other institutional investors also recently made changes to their positions in KMB. Bivin & Associates Inc. bought a new position in shares of Kimberly-Clark during the fourth quarter valued at approximately $26,000. HWG Holdings LP bought a new position in shares of Kimberly-Clark during the fourth quarter valued at approximately $29,000. Roble Belko & Company Inc grew its holdings in Kimberly-Clark by 69.5% in the 1st quarter. Roble Belko & Company Inc now owns 256 shares of the company’s stock worth $32,000 after buying an additional 105 shares in the last quarter. DeDora Capital Inc. bought a new position in Kimberly-Clark in the 1st quarter worth approximately $33,000. Finally, Selective Wealth Management Inc. grew its holdings in Kimberly-Clark by 60.5% in the 1st quarter. Selective Wealth Management Inc. now owns 268 shares of the company’s stock worth $33,000 after buying an additional 101 shares in the last quarter. 74.36% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
A number of brokerages recently issued reports on KMB. UBS Group increased their price objective on Kimberly-Clark from $136.00 to $142.00 and gave the stock a “neutral” rating in a report on Wednesday, July 27th. StockNews.com raised Kimberly-Clark from a “hold” rating to a “buy” rating in a report on Friday, July 22nd. Barclays decreased their price objective on Kimberly-Clark from $129.00 to $124.00 and set an “equal weight” rating for the company in a report on Monday, May 23rd. Finally, Bank of America started coverage on Kimberly-Clark in a report on Wednesday. They issued a “neutral” rating for the company. Two equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $131.15.
Kimberly-Clark Price Performance
Kimberly-Clark (NYSE:KMB – Get Rating) last announced its quarterly earnings data on Tuesday, July 26th. The company reported $1.34 EPS for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.01). Kimberly-Clark had a net margin of 8.87% and a return on equity of 249.60%. The company had revenue of $5.06 billion for the quarter, compared to analyst estimates of $4.99 billion. During the same quarter last year, the company posted $1.47 EPS. Kimberly-Clark’s revenue was up 7.2% on a year-over-year basis. As a group, equities analysts anticipate that Kimberly-Clark Co. will post 5.64 EPS for the current fiscal year.
Kimberly-Clark Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, October 4th. Stockholders of record on Friday, September 9th will be issued a $1.16 dividend. The ex-dividend date of this dividend is Thursday, September 8th. This represents a $4.64 dividend on an annualized basis and a dividend yield of 3.80%. Kimberly-Clark’s payout ratio is currently 87.71%.
Kimberly-Clark Company Profile
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names.
- Get a free copy of the StockNews.com research report on Kimberly-Clark (KMB)
- 3 Banks Worth Considering For Q4
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- MarketBeat: Week in Review 9/12 – 9/16
- Is There a Cure for What is Ailing Teladoc Stock?
- No One Told These 3 Stocks It’s a Down Week
Receive News & Ratings for Kimberly-Clark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark and related companies with MarketBeat.com's FREE daily email newsletter.